Activated Effects of Parathyroid Hormone-Related Protein on Human Hepatic Stellate Cells

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Liang, Fen Fen ^a   Liu, Cui Ping ^a   Li, Li Xuan ^a   Xue, Min Min ^a   Xie, Fang ^a   Guo, Yu ^a   Bai, Lan ^a  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CALCIUM; COLLAGEN TYPE 1; GELATINASE A; MESSENGER RNA; PARATHYROID HORMONE RELATED PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CALCIUM METABOLISM; CELL DIFFERENTIATION; CELL STRAIN; CELL STRAIN LX 2; CONTROLLED STUDY; FIBROGENESIS; GROWTH HORMONE RELEASE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; MYOFIBROBLAST; PROTEIN FUNCTION; PROTEIN SECRETION; REAL TIME POLYMERASE CHAIN REACTION; STELLATE CELL;

ACTINS; BLOTTING, WESTERN; CELL LINE; CELLS, CULTURED; COLLAGEN TYPE I; GENE EXPRESSION; HEPATIC STELLATE CELLS; HUMANS; MATRIX METALLOPROTEINASE 2; MICROSCOPY, FLUORESCENCE; MUSCLE, SMOOTH; PARATHYROID HORMONE-RELATED PROTEIN; PEPTIDE FRAGMENTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84885081819     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076517     Document Type: Article

References (31)

1. McCauley LK, Martin TJ, (2012) Twenty-five years of PTHrP progress: From cancer hormone to multifunctional cytokine. J Bone Miner Res 27: 1231-1239.
2. Horwitz MJ, Tedesco MB, Garcia-Ocana A, Sereika SM, Prebehala L, et al. (2010) Parathyroid hormone-related protein for the treatment of postmenopausal osteoporosis: defining the maximal tolerable dose. J Clin Endocrinol Metab 95: 1279-1287.
3. Bisello A, Horwitz MJ, Stewart AF, (2004) Parathyroid hormone-related protein: an essential physiological regulator of adult bone mass. Endocrinology 145: 3551-3553.
4. Horwitz MJ, Tedesco MB, Gundberg C, Garcia-Ocana A, Stewart AF, (2003) Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 88: 569-575.
5. Wysolmerski JJ, (2012) Parathyroid hormone-related protein: an update. J Clin Endocrinol Metab 97: 2947-2956.
6. Ardura JA, Rayego-Mateos S, Ramila D, Ruiz-Ortega M, Esbrit P, (2010) Parathyroid hormone-related protein promotes epithelial-mesenchymal transition. J Am Soc Nephrol 21: 237-248.
7. Friedman SL, (2000) Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J Biol Chem 275: 2247-2250.
8. Xu L, Hui AY, Albanis E, Arthur MJ, O'Byrne SM, et al. (2005) Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 54: 142-151.
9. Bataller R, Brenner DA, (2005) Liver fibrosis. J. Clin. Invest 115: 209-218.
10. Bataller R, Brenner DA, (2001) Hepatic stellate cells as a target for the treatment of liver fibrosis. Semin Liver Dis 21: 437-452.
11. Gressner AM, Weiskirchen R, Breitkopf K, Dooley S, (2002) Roles of TGF-beta in hepatic fibrosis. Front Biosci 7: d793-d807.
12. Kisseleva T, Brenner DA, (2007) Role of hepatic stellate cells in fibrogenesis and the reversal of fibrosis. J Gastroenterol Hepatol 22Suppl 1: S73-S78.
13. Friedman SL, (2008) Hepatic fibrosis-Overview. Toxicology 254: 120-129.
14. Philbrick WM, Wysolmerski JJ, Galbraith S, Holt E, Orloff JJ, et al. (1996) Defining the roles of parathyroid hormone-related protein in normal physiology. Physiol Rev 76: 127-173.
15. Urena P, Kong XF, Abou-Samra AB, Juppner H, Kronenberg HM, et al. (1993) Parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acids are widely distributed in rat tissues. Endocrinology 133: 617-623.
16. Funk JL, Moser AH, Grunfeld C, Feingold KR, (1997) Parathyroid hormone-related protein is induced in the adult liver during endotoxemia and stimulates the hepatic acute phase response. Endocrinology 138: 2665-2673.
17. Funk JL, Krul EJ, Moser AH, Shigenaga JK, Strewler GJ, et al. (1993) Endotoxin increases parathyroid hormone-related protein mRNA levels in mouse spleen. Mediation by tumor necrosis factor. J Clin Invest 92: 2546-2552.
18. JP N, (1975) The role of endotoxin in liver injury. Gastroenterology 69: 1346-1356.
19. Nolan JP, (2010) The role of intestinal endotoxin in liver injury: a long and evolving history. Hepatology 52: 1829-1835.
20. Iredale JP, (2001) Hepatic stellate cell behavior during resolution of liver injury. Semin Liver Dis 21: 427-436.
21. Kemp BE, Moseley JM, Rodda CP, Ebeling PR, Wettenhall RE, et al. (1987) Parathyroid hormone-related protein of malignancy: active synthetic fragments. Science 238: 1568-1570.
22. Liu C, Chen J, Guo Y, Yang L, Zhao C, et al. (2011) The expression of PTHLH in human gastric mucosa enterochromaffin-like cells. Dig Dis Sci 56: 993-998.
23. Funk JL, Moser AH, Strewler GJ, Feingold KR, Grunfeld C, (1996) Parathyroid hormone-related protein is induced during lethal endotoxemia and contributes to endotoxin-induced mortality in rodents. Mol Med 2: 204-210.
24. Ardura JA, Berruguete R, Ramila D, Alvarez-Arroyo MV, Esbrit P, (2008) Parathyroid hormone-related protein interacts with vascular endothelial growth factor to promote fibrogenesis in the obstructed mouse kidney. Am J Physiol Renal Physiol 295: F415-F425.
25. Fabrega E, Rivero M, Pons-Romero F, Garcia-Unzueta MT, Amado JA, (2000) Parathyroid hormone-related protein in liver cirrhosis. Dig Dis Sci 45: 703.
26. Breitkopf K, Haas S, Wiercinska E, Singer MV, Dooley S, (2005) Anti-TGF-beta strategies for the treatment of chronic liver disease. Alcohol Clin Exp Res 29: 121S-131S.
27. Henry JG, Mitnick M, Dann PR, Stewart AF, (1997) Parathyroid hormone-related protein-(1-36) is biologically active when administered subcutaneously to humans. J Clin Endocrinol Metab 82: 900-906.
28. Horwitz MJ, Tedesco MB, Gundberg C, Garcia-Ocana A, Stewart AF, (2003) Short-term, high-dose parathyroid hormone-related protein as a skeletal anabolic agent for the treatment of postmenopausal osteoporosis. J Clin Endocrinol Metab 88: 569-575.
29. Collier JD, Ninkovic M, Compston JE, (2002) Guidelines on the management of osteoporosis associated with chronic liver disease. Gut 50Suppl 1: i1-i9.
30. Horwitz MJ, Tedesco MB, Sereika SM, Prebehala L, Gundberg CM, et al. (2011) A 7-day continuous infusion of PTH or PTHrP suppresses bone formation and uncouples bone turnover. J Bone Miner Res 26: 2287-2297.
31. Wolzt M, Schmetterer L, Dorner G, Zelger G, Entlicher J, et al. (1997) Hemodynamic effects of parathyroid hormone-related peptide-(1-34) in humans. J Clin Endocrinol Metab 82: 2548-2551.